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CLINICAL INVESTIGATION
Characteristics and Outcomes of Dementia Patients Who Receive
Inpatient Palliative Care Consultation
Neema Sharda, MD,*† Kahli Zietlow, MD,‡ Serena Wong, DO,*†
Maragatha Kuchibhatla, PhD,†§ and Kimberly S. Johnson, MD*†¶
BACKGROUND/OBJECTIVES: Acute hospitalization may
be an ideal opportunity to introduce palliative care to demen-
tia patients, who may benefit from symptom management
and goals of care discussions. We know little about patients
who receive inpatient palliative care consultations (IPCCs).
DESIGN: Retrospective analysis using electronic medical
record.
SETTING: Tertiary academic medical center and affiliated
community hospital.
PARTICIPANTS: Patients with dementia by International
Classification of Diseases diagnosis, 65 years or older, hos-
pitalized between July 1, 2015, and December 31, 2015.
MEASUREMENTS: We used χ2 and t-test/Mann-Whitney
U test to compare characteristics (living arrangement,
advanced dementia markers, diagnoses of delirium and
dementia with behavior disturbance, and admitting diagno-
sis) and outcomes (change in code status, length of stay
[LOS], discharge disposition, and discharge medications for
symptom management) of patients who did and did not
receive IPCC. Patients were matched on sex, age, and race.
RESULTS: Among 927 hospitalized patients with dementia,
17% received IPCC (N = 157). Patients who received IPCC
were more likely to be admitted from a nursing facility
(35.7% vs 12.7%; P < .0001), experience delirium (71.3% vs
57.3%; P = .01), have behavior disturbance (23.6% vs
13.4%; P = .02), have a pressure ulcer at admission (26.1%
vs 11.5%; P = .001), have hypernatremia (12.7% vs 3.2%;
P = .002), and be bedbound (20.4% vs 3.2%; P < .000).
Patients who received IPCC had a longer LOS (median = 5.9
vs 4.3 days; P = .004) and were more likely to be discharged
to hospice (56% vs 3.1%; P < .0001). Patients with IPCC
were more likely to have a discharge code status of do not
attempt resuscitation (89% vs 46%). There was no significant
difference in comfort medications at discharge between
groups.
CONCLUSIONS: Patients who received IPCC had evidence
of more advanced dementia. These patients were more
likely to change their code status and enroll in hospice.
IPCC may be useful to prioritize patient-centered care and
discuss what matters most to patients and families. J Am
Geriatr Soc 68:2027-2033, 2020.
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As of 2019, an estimated 5.8 million Americans hadbeen diagnosed with Alzheimerʼs disease. By 2050,
that number is projected to grow to 13.8 million.1
Alzheimerʼs disease and other types of dementia signifi-
cantly impair the quality of life of the affected patient and
his/her family and caregivers. Furthermore, the costs related
to dementia care are staggering. Data from the Health and
Retirement Study suggest that in the last 5 years of life,
total costs (including Medicare, Medicaid, private insur-
ance, out-of-pocket spending, and informal care) for
patients with dementia exceed those of patients with heart
disease or cancer.2
Additionally, patients with dementia are at risk for
poor outcomes in the acute care setting. Compared to hos-
pitalized patients without dementia, studies suggest that
patients with dementia have longer lengths of stay, have
worse symptom management, are more likely to die in the
hospital, and have higher per capita hospital costs.3,4 Pallia-
tive care has been shown to play an important role in
improving quality of life, reducing caregiver burden, and
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lowering end-of-life healthcare costs for those with terminal
illness.5-8 Inpatient palliative care consultation (IPCC) is
associated with better symptom management and communi-
cation, lower rates of rehospitalization, higher rates of
hospice enrollment, and lower costs due to less resource-
intensive care.9
Although dementia is a progressive and ultimately ter-
minal diagnosis, there is little literature examining the role
of palliative care in dementia. Two recent reviews assessing
palliative care interventions in dementia care suggest insuffi-
cient evidence to draw conclusions about benefits.10,11 Spe-
cifically, studies of IPCCs in hospitalized patients with
dementia have reported mixed results. In a small number of
studies, IPCC has been associated with improvements in
family membersʼ ratings of the quality of end-of-life care,
reduced pharmacy costs, more frequent assessment and
treatment of symptoms, greater likelihood of addressing
spiritual needs, and increased use of hospice care. In other
studies, IPCC for patients with advanced dementia has not
significantly impacted the use of life-sustaining treatments,
hospital or emergency department visits, or caregiver dis-
tress.9,12-14 The available studies on IPCC in dementia care
have several limitations, including small sample size, hetero-
geneous interventions and outcomes, and difficulty
assessing outcomes (ie, assessing pain control in patients
with advanced dementia). Given the limitations of current
research and the potential benefits of IPCC in improving
quality and reducing costs, this study examines the associa-
tion of IPCC with care outcomes in hospitalized patients
with dementia.
METHODS
Data Source and Population
We performed a retrospective electronic medical record
(EMR) review of patients aged 65 years and older with a
diagnosis of dementia based on International Classification
of Diseases, Ninth Revision (ICD-9) (code 290, 290.0,
290.1, 290.20, 290.4, 290.40, 290.42, 291.2, 292.82,
294.1, 294.10, 294.11, 294.20, 294.21, 331.1, 331.19, or
331.82) and International Classification of Diseases, Tenth
Revision (ICD-10) (code F01.50, F01.51, F02.80, F02.81,
F03, F03.90, F03.91, F10.27, F10.97, F13.97, F19.97,
G31.09, or G31.83) who were hospitalized at Duke Univer-
sity Hospital or Duke Regional Hospital in Durham, NC,
between July 1, 2015, and December 31, 2015. Both hospi-
tals use a shared EMR. We used the clinical research and
quality improvement query tool to identify patients of inter-
est. To create our study sample, we identified the subgroup
of dementia patients who received an IPCC. Each of these
patients was then matched (1:1 matching) based on race,
age (within 5 years), and sex with a dementia patient who
did not receive an IPCC. The chart abstraction was com-
pleted for all dementia patients receiving IPCC and the mat-
ched non-IPCC cohort. The study team developed a list of
common variables and definitions for EMR abstraction,
which was completed by one team member. Data were
recorded in the Research Electronic Data Capture database,
a secure, web-based application that provides audit trails
for data tracking and export procedures.15 The study was
approved by the Duke University Health Systemʼs Institu-
tional Review Board.
Variables
We extracted the following variables from the EMR on all
patients in our sample.
1. Demographics: age, sex, race, ethnicity, marital sta-
tus, and living arrangement before admission (home, nurs-
ing home, or assisted living facility).
2. Clinical Data: Based on author consensus and avail-
ability of data in the EMR, we identified four indicators of
advanced dementia. These include: sodium level greater than
145 mmol/L on admission, weight loss greater than 10% in
last year, presence of pressure ulcer at admission (from review
of nursing notes and wound care team consultation), and
baseline ambulatory status (from case management assess-
ments and initial physical therapy evaluation notes). These
markers were consistently reported in the EMR and have
been associated with advanced dementia.16-18 We also
recorded data on whether patients had an ICD-9 or ICD-10
code at discharge indicating dementia with behavioral distur-
bance and whether patients were diagnosed with delirium
during hospitalization. Delirium diagnosis was determined on
review of all discharge diagnoses, and included acute delir-
ium, encephalopathy, and altered mental status. We recorded
the primary reason for hospital admission, which was deter-
mined based on the assessment and plan in the admission his-
tory and physical. Finally, for patients who received IPCC,
we recorded reason for consultation from the initial consulta-
tion electronic order.
3. Code Status: We recorded whether patientʼs code status
order in the EMR at admission and discharge was do not
attempt resuscitation (DNAR) or full code. Admission code
status was the order placed on the date of admission. Discharge
code status was the most recent order before live discharge or
death.
4. Hospital Outcomes: These included length of stay
(LOS) and discharge disposition, which we categorized as
hospice, home (with or without home health services), facil-
ity (skilled nursing facility, nursing home, or assisted living
facility), and death.
5. Discharge Medications for Symptom Management:
We recorded whether patients were continued and/or
started on medications to control symptoms from the hos-
pital discharge summary (eg, pain, dyspnea, anxiety),
including opiates, benzodiazepines, antipsychotics, and
acetaminophen.
Statistical Analysis
We used summary statistics (means and medians for continu-
ous variables; counts and percentages for categorical variables)
to describe the sample. We compared characteristics of demen-
tia patients who received IPCC to those who did not receive
IPCC using either t-tests (normal distribution) or the Mann-
Whitney U-test (nonnormal distribution) for continuous
variables and χ2 tests for categorical variables. P <.05 was
considered statistically significant. Analyses were performed
using the SAS 9.4 statistical software (SAS Institute Inc).
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RESULTS
Sample Characteristics
During the study period, 927 patients with an ICD diag-
nosis of dementia were admitted to a hospital included in
our EMR review; 17% (N = 157) of them received an
IPCC. We matched the 157 patients who received an
IPCC to 157 patients who did not receive IPCC based on
age, race, and sex, yielding a total sample size of
314 (Figure 1).
Table 1 includes sample characteristics. The mean age
of all patients was 84 years, 63% were female, and 69%
were white. There were no differences between the two
groups in sex, ethnicity, race, or marital status. Of patients
who received an IPCC, the most common indications for
consultation (provider teams requesting IPCC were able to
list more than one indication for consultation request) were
goals of care discussion (N = 125) and symptom manage-
ment (N = 48). Patients who received IPCC were more
likely to have been admitted from the nursing home (36%
vs 13%; P < .0001), have a diagnosis of dementia with
behavior disturbance (24% vs 13%; P = .02), and have a
diagnosis of delirium during hospitalization (71% vs 57%;
P < .01). The most common reason for admission for both
groups was altered mental status (28% among patients
who did not receive IPCC and 29% among patients who
did receive IPCC; P = .80). Other common reasons for
admission included urinary tract infection (9.6% among
patients with IPCC and 15.9% among patients without
IPCC) and fracture (7.6% among patients with IPCC and
8.3% among patients without IPCC).
Markers of Advanced Dementia
Patients who received IPCC had evidence of more advanced
disease. Specifically, patients receiving an IPCC were more
likely at admission to have: (1) greater than 10% weight
loss in past year (22% vs 16%; P = .15); (2) a pressure
wound (26% vs 12%; P < .01); (3) hypernatremia (13% vs
3%; P < .01); and (4) bedbound ambulatory status (20.4%
vs 3.2%; P < .0001).
Code Status
There was no significant difference in code status between
groups at admission; however, at discharge, rates were sig-
nificantly higher for those with IPCC compared to those
without IPCC (Figure 2). Nearly 50% (N = 78) of patients
in the IPCC group were DNAR on admission compared to
39% (N = 61) of those who did not receive IPCC
(P = .053). At discharge, 89% (N = 139) of those with
IPCC were DNAR compared to 46% (N = 73) of those in
the non-IPCC group (P < .0001). Notably, of the 27 patients
who died in the hospital, only 1 had full code documented
as his/her discharge code status; this patient did not receive
an IPCC.
Figure 1. Inclusion criteria search results. [Color figure can be viewed at wileyonlinelibrary.com]
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Hospital Outcomes
Table 2 outlines outcomes. Patients who received IPCC had
a longer median LOS (5.9 vs 4.3 days; P = .004). Patients
who received IPCC had significantly different discharge dis-
positions than those who did not receive IPCC (P < .01).
Patients who received IPCC were more likely to die in the
hospital (13% vs 4%) or be discharged to hospice (56% vs
3%), and less likely to be discharged to home (9% vs 37%)
or a facility (21% vs 54%).
Table 1. Sample Characteristics
Characteristics
No IPCC IPCC Total
P Value(n = 157) (n = 157) (n = 314)
Age, mean (SD), y 83.9 (8.0) 84.3 (8.3) 84.1 (8.1) .414
Sex (female) 99 (63.1) 98 (62.4) 197 (62.7) .907
Race .208
White 111 (70.7) 107 (68.2) 218 (69.4)
Black 41 (26.1) 45 (28.7) 86 (27.4)
Ethnicity .562
Hispanic 2 (1.3) 1 (0.6) 3 (1)
Non-Hispanic 155 (98.7) 156 (99.4) 311 (99)
Marital status .952
Single 17 (10.8) 14 (8.9) 31 (9.9)
Widowed 71 (45.2) 76 (48.4) 147 (46.8)
Divorced 10 (6.4) 9 (5.7) 19 (6.1)
Married 56 (35.7) 54 (34.4) 110 (35)
Prior living arrangement <.0001
Home 109 (69.4) 84 (53.5) 193 (61.4)
Nursing home/SNF 20 (12.7) 56 (35.7) 76 (24.2)
Assisted living facility 28 (17.8) 16 (10.2) 44 (14.0)
Dementia with behavior disturbance 21 (13.4) 37 (23.6) 58 (18.5) .02
Delirium diagnosis 90 (57.3) 112 (71.3) 202 (64.3) .01
Markers of advanced dementia
Weight loss >10% in 1 y 25 (15.9) 35 (22.3) 60 (19.1) .151
Pressure ulcer at admission 18 (11.5) 41 (26.1) 59 (18.8) .001
Sodium >145 mmol/L 5 (3.2) 20 (12.7) 25 (8.0) .002
Ambulatory without assistive device 36 (22.9) 21 (13.4) 57 (18.2) .028
Bedbound 5 (3.2) 32 (20.4) 37 (11.8) <.0001
Note: Data are given as number (percentage), unless otherwise indicated.
Abbreviations: IPCC, inpatient palliative care consultation; SNF, skilled nursing facility.
Figure 2. Do not attempt resuscitation (DNAR) status at admission and discharge related to inpatient palliative care consultation
(IPCC) (N = 157 in each group).
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Indicators of Symptom Management
We examined discharge medications for symptom manage-
ment among patients who did not die in the hospital or
enroll in hospice at discharge. For patients discharged to
home or a facility, there was no difference between the two
groups in discharge medications for comfort, including opi-
ates, benzodiazepines, antipsychotic medications, and acet-
aminophen. Overall, 69 patients (35.6%) were prescribed
opiates, 29 patients (14.9%) were prescribed benzodiaze-
pines, 41 patients (21.1%) were prescribed antipsychotic
medications, and 112 patients (57.7%) were prescribed
acetaminophen.
DISCUSSION
Despite the terminal nature of dementia and the high rates
of healthcare utilization in this disease, a small proportion
of patients with dementia receive palliative care consulta-
tion, and palliative care consultation has not been well stud-
ied in this population. In this study at an academic and
affiliated community hospital, we found that 17% of hospi-
talized patients with dementia received an IPCC. Notably, a
large retrospective cross-sectional study (N = 57,753 dece-
dents) in the Veterans Affairs health system comparing
quality of end-of-life care provided for different serious ill-
nesses found 61.4% of patients with dementia (6.4% of
their sample) received palliative care consultation within the
last 90 days of life. There was no differentiation between
inpatient and outpatient consultation.9 As compared to sim-
ilar patients who did not receive an IPCC, we found that
patients who received an IPCC had more signs of advanced
dementia and higher rates of delirium during hospitaliza-
tion, were more likely to die in the hospital or be dis-
charged to hospice, and were more likely to change their
code status from full code to DNAR. The increased dis-
charge to hospice and change in code status suggest IPCC
resulted in increased goals of care discussions and possibly
lower healthcare utilization, and suggest a benefit of IPCC
for hospitalized patients with dementia. We noted that
patients who received IPCC had longer LOS compared to
those who did not, but this is confounded by the fact that
patients who received IPCC had more delirium and
advanced dementia, which may have eventually triggered
the IPCC.
The most common reason for IPCC was to address
goals of care, followed by symptom management. This is
consistent with other published literature on IPCC; advance
care planning discussion was the most common reason for
IPCC across 78 US hospitals in the Palliative Care Quality
Network collaborative.19 Given the most common reason
for IPCC, our results suggest that IPCC offers an opportu-
nity to discuss what matters most to patients. IPCC targets
important components of the “Age-Friendly Health
System,” specifically advance care planning to ensure
patients receive care and symptom management consistent
with their preferences.20,21 Whether DNAR code status and
enrollment in hospice constitute a “benefit” to patients
depends on the patient and family values, but we believe
the increased frequency of hospice enrollment and changed
code status serve as surrogacy markers for improved goals
of care discussions. This is consistent with other literature
showing improved discussions about prognosis, goals of
care, and decision making when an IPCC occurs in hospi-
talized patients with advanced dementia.14
Though our sample size is small, we found no differ-
ence in symptomatic medication prescriptions at discharge
between the two groups (excluding those who were dis-
charged on hospice). Based on these results, we do not
know how IPCC affects symptom management. Notably,
prescribing patterns represent only one element of symptom
management, particularly in dementia when pharmaceuti-
cals are typically not considered first line for behavioral or
psychological disturbances, and thus this remains an area
that requires ongoing study.
Acknowledging that 17% of hospitalized patients with
a diagnosis of dementia received an IPCC, we recognize










Length of stay, median, d 4.3 5.9 5.1 .004
Discharge disposition <.0001
Hospital death 6 (3.8) 21 (13.4) 27 (8.6)
Discharge to hospice 5 (3.1) 88 (56) 93 (29.6)
Discharge to facility 89 (56.5) 35 (22.3) 124 (39.5)








Comfort medications at discharge
Opiate 51 (34.9) 18 (37.5) 69 (35.6) .747
Benzodiazepine 21 (18.5) 8 (16.7) 29 (14.9) .700
Antipsychotic 27 (18.5) 14 (29.2) 41 (21.1) .116
Acetaminophen 89 (61.0) 23 (47.9) 112 (57.7) .113
Note: Data are given as number (percentage), unless otherwise indicated.
Abbreviation: IPCC, inpatient palliative care consultation.
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for a broader group of patients. A scoping review assessed
existing literature to identify potential barriers for dementia
patients to access palliative care. Four key types of barriers
were recognized: administrative issues (eg, financial models
for end-of-life care, access to palliative care services), edu-
cation, communication, and provider/staff attitudes toward
end-of-life care.22 Particularly during acute admissions,
providers may be focused on correcting reversible issues
that prompted the hospital admission, and may miss oppor-
tunities to focus on the bigger picture concerning the
patientʼs diagnosis of dementia and ultimate prognosis.
Our study suggests that IPCC provides an opportunity to
fill these gaps in dementia patientsʼ care. Furthermore,
patients who did receive IPCC were more likely to have
advanced dementia. Early use of palliative care principles,
and specifically having goals of care discussions when
dementia is less severe, may provide additional benefit to
patients and caregivers. Earlier adoption of palliative care
in cancer patients has been shown to improve symptom
intensity and quality of life in cancer care, and there is
growing evidence that earlier palliative care is also advanta-
geous to clinical outcomes and quality of life in patients
with heart failure.23,24
This study has several important limitations. This is a
retrospective analysis performed at a single academic center
and affiliated community hospital. Our data are from 2015,
which was the most recent, complete data set available at
the time of study initiation; notably, a 2019 systematic
review published suggests a beneficial trend for dementia
patients with palliative care consultation in several
domains, including goals of care discussions, symptom
management, and prescribing behavior.25 We also acknowl-
edge that utilization of ICD codes to capture dementia diag-
noses is imperfect, and patients with clinical diagnoses of
dementia hospitalized within our institution may not have
been included in this study as a result. Our institution is a
tertiary referral center, and our study population was pre-
dominantly white and non-Hispanic, which limits generaliz-
ability of our data. Given the retrospective nature of the
study, we were unable to capture patient or caregiver
quality-of-life data or confirm whether the IPCC interven-
tions aligned with the patientsʼ attitudes and values. Addi-
tionally, there was no long-term follow up on patient
outcomes. We used prescribing patterns as a surrogate for
symptom management, and thus incompletely captured the
role of IPCC on symptom management. Finally, to identify
the sample of non-IPCC patients, we randomly matched
IPCC patients with non-IPCC patients based on age, sex,
and race. There is significant variability in dementia diagno-
ses not captured in ICD codes. Additionally, other variables
related to cognitive/functional status and prognosis are not
consistently reported in the EMR. Given this, our method
may not have accounted for all important differences and
similarities in the two groups, which could have impacted
decisions about IPCC and subsequently other aspects of
care (LOS, DNAR orders, hospice). Despite these limita-
tions, our findings are consistent with other studies of
IPCC, which show increased rates of advance care planning
and hospice enrollment following consultation.9 Addition-
ally, studies indicate that palliative care is often requested
for those with evidence of more advanced disease,26 as
noted in our work.
Given the progressive and ultimately terminal nature of
dementia, it makes intuitive sense for early palliative care
involvement to help guide targeted symptom management
and end-of-life care. This study suggests a benefit for IPCC
in admitted patients with dementia, particularly in improving
communication and increasing hospice enrollment. In fact,
early utilization of palliative care principles may lead to less
need for IPCC; improved goals of care conversations
between patients, caregivers, and primary care teams, with
outpatient palliative care, may lead to decisions to adopt a
DNAR code status, avoid hospitalizations, and consider a
hospice transition without an inpatient stay. Additional stud-
ies are needed to learn how to best identify patients who can
benefit from IPCC and to understand whether such interven-
tions align with patient values and improve quality of life.
More research is needed across a variety of care settings,
including in home and facility, to observe how palliative care
impacts patient and family-centered outcomes and thus
understand how to improve the care of dementia patients.
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